A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (Trust TSC)

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Germaine, Jack (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date5/10/23 → 4/10/25

Keywords

  • Clinical trial
  • 1042-TSC-3001